Rapid Point-of-Care Diagnosis and Surveillance of COVID-19 by Fluorescent Lateral Flow Assay Based on the Novel Aggregation-Induced Emission (AIE) Technology
Grant Data
Project Title
Rapid Point-of-Care Diagnosis and Surveillance of COVID-19 by Fluorescent Lateral Flow Assay Based on the Novel Aggregation-Induced Emission (AIE) Technology
Principal Investigator
Professor Teng, Lee Lee
(Project Coordinator (PC))
Duration
8
Start Date
2020-09-15
Completion Date
2021-05-14
Amount
1666481
Conference Title
Rapid Point-of-Care Diagnosis and Surveillance of COVID-19 by Fluorescent Lateral Flow Assay Based on the Novel Aggregation-Induced Emission (AIE) Technology
Keywords
COVID-19, Fluorescent Lateral Flow Assay Based, Novel Aggregation-Induced Emission (AIE), Point-of-Care Diagnosis, Surveillance
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
SST/109/20GP
Grant Type
Public Sector Trial Scheme
Funding Year
2020
Status
Completed
Objectives
In this proposed trial project, we plan to engage 1) Department of Microbiology, Queen Mary Hospital (QMH), 2) Department of Paediatrics and Adolescent Medicine, QHM, and 3) Department of Pathology (Microbiology), QEH to test and evaluate our prototypes. In the current COVID-19 outbreak, QMH and QEH have been heavily involved in testing all suspected cases in our locality and have access to a huge number and a wide variety of specimen types. Department of Paediatrics and Adolescent Medicine also admits patients with COVID-19. Therefore, with their supports there will be no doubt that sufficient quantities of patient samples can be collected for trial.